Dynavax Technologies has revealed promising topline outcomes from the initial part of its Phase I/II clinical trial, ...

Results from the first part of a Phase I/II trial (NCT06569823) showed that Z-1018 generated immune responses comparable to ...

The Emeryville, California-based biotech has just released topline results from a phase 1/2 head-to-head study comparing its ...

Shares in Dynavax Technologies Corporation closed 5% higher Thursday after the presentation of positive top-line results from ...

Bavarian Nordic AS (BVNKF) reports a 33% revenue increase and secures significant public preparedness contracts, while ...

Twin Health has raised another $53 million to fund its 'digital twin' platform, which provides a model of a patient's unique ...